Hand Perfusion and Pulse Oximetry Performance
Launched by MAYO CLINIC · Apr 7, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Hand Perfusion and Pulse Oximetry Performance," is designed to compare two ways of measuring oxygen levels in the blood. Researchers will look at readings from pulse oximeters, which are devices that clip onto your finger, against actual blood samples taken at the same time from participants. This study aims to ensure that these devices work accurately, especially for people with different skin tones, as there can be differences in how well they perform.
To participate in this study, you need to be a healthy adult (between 18 and 75 years old) who is a non-smoker and has a body mass index (BMI) between 18 and 30. The researchers want to include a balanced number of men and women, as well as individuals with darker skin tones, to better understand how the devices work for everyone. Participants will be recruited from the local community and the Mayo Medical Center, and they should not have any heart or lung diseases or be taking medications that could affect the study results. If you decide to participate, you’ll help improve the accuracy of oxygen level measurements for all patients in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthy adult men and women of all races and ethnic backgrounds recruited from faculty and staff of the Mayo Medical Center and from Rochester, MN and surrounding communities.
- • Equal number of male and female participants to address potential sex differences in physiology.
- • We will intentionally recruit subjects with dark skin because of the issues surrounding accuracy of pulse oximetry and skin tone.
- • Non-smokers
- • BMIs between 18-30 kg·m-2.
- • Female subjects will be non-pregnant.
- • Free of cardiopulmonary diseases or other conditions and/or taking medications that might affect pulse oximeter-based estimates of arterial saturation.
- • All inclusion and exclusion criteria are at the discretion of the Principal Investigator.
- • At least 8 of the subjects will have Fitzpatrick Skin Type of IV to VI.
- Exclusion Criteria:
- • • Children under the age of 18 will not be studied. We will exclude children less than 18 years of age because they are unable to give consent, and because these studies are non-therapeutic.
About Mayo Clinic
Mayo Clinic is a renowned nonprofit medical practice and research institution dedicated to providing comprehensive healthcare and advancing medical knowledge through innovative research and education. With a commitment to patient-centered care, Mayo Clinic conducts numerous clinical trials aimed at exploring new therapies and improving treatment outcomes across various disciplines. Leveraging a multidisciplinary approach, the institution collaborates with leading experts and cutting-edge technology to ensure rigorous scientific standards and ethical practices in all its research endeavors. Through its trials, Mayo Clinic seeks to translate breakthroughs in science into tangible benefits for patients, fostering advancements in medicine that enhance health and quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rochester, Minnesota, United States
Patients applied
Trial Officials
Michael Joyner, MD
Principal Investigator
Mayo Clinic
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported